Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | INSR | P06213 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ATP4A | P20648 | 6/20 | 0.46 |
| ▸ | ATP4B | P51164 | 6/20 | 0.46 |
| ▸ | APP | P05067 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1105772 | 0.79 | INSR (0.52) | KAT8INSRCNR2 | |
| SCHEMBL11133110 | 0.78 | INSR (0.66) | KAT8MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL11133107 | 0.78 | INSR (0.66) | KAT8MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL611168 | 0.77 | TP53 (0.49) | MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL715557 | 0.73 | MAPT (0.76) | KAT8MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL715558 | 0.73 | MAPT (0.76) | KAT8MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL9100970 | 0.73 | INSR (0.45) | INSRCNR2 | |
| SCHEMBL9100973 | 0.73 | INSR (0.45) | INSRCNR2 | |
| SCHEMBL9722835 | 0.72 | ALDH1A1 (0.58) | MEN1MAPTKMT2ASMN1; SMN2NPC1 | |
| SCHEMBL7719119 | 0.71 | CHRM2 (0.54) | MEN1MAPTKMT2AINSRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130045480-A1 | Novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes - useful or detection or quantification of desirable target molecules | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2013-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045480-A1 | Novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes - useful or detection or quantification of desirable target molecules | ANXA5, DCLRE1B, ANXA4 | KAT8 3770/4885MEN1 4221/4885MAPT 3649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.